Gubra A/S

Research Gubra A/S (GUBRA) on Bullrun: market cap DKK 5.27B, P/E 3.1. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGUBRA
• ExchangeCO
• CountryDenmark
• SectorHealthcare
• IndustryBiotechnology
• CurrencyDKK
• Market capDKK 5.27B
• P/E3.1
• Financial periodFY2025
• RevenueDKK 2.64B
• Revenue growth892.2%
• Net incomeDKK 1.69B
• Free cash flowDKK 1.69B
• Gross margin97.0%

Valuation Snapshot

latest market cap is DKK 5.27B; P/E is 3.1.

About Gubra A/S

Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green. The company offers preclinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry;

Frequently asked questions

What is Gubra A/S's market cap?

Gubra A/S's market capitalization is DKK 5.27B.

What is Gubra A/S's P/E ratio?

Gubra A/S's price-to-earnings (P/E) ratio is 3.1.

What does Gubra A/S do?

Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green.